# B.-C. Liao

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/b-c-liao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 2 |
| i10-index | 0 |
| Last Known Institution | Taichung Veterans General Hospital |
| OpenAlex ID | https://openalex.org/A5065384968 |
| Works | 3 |

## Researcher papers

- [P4.07D.04 Trofuse-019: A Phase 3 Study of Adjuvant Pembrolizumab with or without Sac-TMTfor Resectable Stage II-IIIB (N2) NSCLC](https://scholariq.org/papers/p4-07d-04-trofuse-019-a-phase-3-study-of-adjuvant-pembrolizumab-with-or-without/)
- [EP08.02-127 Resistance Mechanisms to Osimertinib in Advanced EGFR-mutated NSCLC: A Single Institution Prospective Cohort Study](https://scholariq.org/papers/ep08-02-127-resistance-mechanisms-to-osimertinib-in-advanced-egfr-mutated-nsclc/)
- [Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study](https://scholariq.org/papers/acalabrutinib-versus-venetoclax-plus-obinutuzumab-in-treatment-naive-chronic/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)

## Researcher university

- [Taichung Veterans General Hospital](https://scholariq.org/institutions/taichung-veterans-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.